Literature DB >> 21377336

Activities of daily living, social functioning and their determinants in persons with psychotic disorder.

S Viertiö1, A Tuulio-Henriksson, J Perälä, S I Saarni, S Koskinen, M Sihvonen, J Lönnqvist, J Suvisaari.   

Abstract

OBJECTIVE: The determinants of everyday functioning in persons with psychotic disorder have not been widely studied in community dwelling samples. Our aim was to investigate limitations in everyday functioning among subjects with psychotic disorders in a population-based study.
METHOD: Everyday functioning was assessed in a nationally representative sample of 7112 persons aged 30+ using interviewer observations and self-reports, while verbal fluency and memory were also measured. Diagnostic assessment of DSM-IV psychotic disorders was based on SCID interview and case-note data. Lifetime-ever diagnoses of psychotic disorder were classified into schizophrenia (n=61), other non-affective psychotic disorders (ONAP) (n=79) and affective psychoses (n=45). RESULT: Non-affective psychotic disorder was significantly associated with limitations in everyday functioning, as well as with deficits in verbal fluency and memory. Negative symptoms, depression, age, gender, verbal memory deficits, and reduced visual acuity were predictors of limitations in everyday functioning even after controlling for sociodemographic factors and chronic medical conditions, and difficulties in social functioning were also related to expressive speech problems.
CONCLUSION: Persons with schizophrenia and ONAP have significantly more problems in everyday functioning than the general population. One significant predictor of problems was reduced visual acuity, which at least in some situations could be easily corrected.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21377336     DOI: 10.1016/j.eurpsy.2010.12.005

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  15 in total

Review 1.  Association Between REELIN Gene Polymorphisms (rs7341475 and rs262355) and Risk of Schizophrenia: an Updated Meta-analysis.

Authors:  Sadiatul Marzan; Md Abdul Aziz; Mohammad Safiqul Islam
Journal:  J Mol Neurosci       Date:  2020-09-05       Impact factor: 3.444

Review 2.  Assessment of capacity in an aging society.

Authors:  Jennifer Moye; Daniel C Marson; Barry Edelstein
Journal:  Am Psychol       Date:  2013-04

Review 3.  Schizophrenia and Infections: The Eyes Have It.

Authors:  E Fuller Torrey; Robert H Yolken
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

Review 4.  Virtual reality for treatment compliance for people with serious mental illness.

Authors:  Maritta Välimäki; Heli M Hätönen; Mari E Lahti; Marjo Kurki; Anja Hottinen; Kiki Metsäranta; Tanja Riihimäki; Clive E Adams
Journal:  Cochrane Database Syst Rev       Date:  2014-10-08

5.  Predicting functional remission in patients with schizophrenia: a cross-sectional study of symptomatic remission, psychosocial remission, functioning, and clinical outcome.

Authors:  Marcelo Valencia; Ana Fresán; Yoram Barak; Francisco Juárez; Raul Escamilla; Ricardo Saracco
Journal:  Neuropsychiatr Dis Treat       Date:  2015-09-10       Impact factor: 2.570

6.  Lack of tolerable treatment options for patients with schizophrenia.

Authors:  Leslie Citrome; Anna Eramo; Clement Francois; Ruth Duffy; Susan N Legacy; Steve J Offord; Holly B Krasa; Stephen S Johnston; Alice Guiraud-Diawara; Siddhesh A Kamat; Patricia Rohman
Journal:  Neuropsychiatr Dis Treat       Date:  2015-12-16       Impact factor: 2.570

7.  Social Dysfunction and Diet Outcomes in People with Psychosis.

Authors:  Doreen Mucheru; Mary-Claire Hanlon; Linda E Campbell; Mark McEvoy; Lesley MacDonald-Wicks
Journal:  Nutrients       Date:  2017-01-19       Impact factor: 5.717

Review 8.  Schizophrenia and risk of dementia: a meta-analysis study.

Authors:  Laisheng Cai; Jingwei Huang
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-13       Impact factor: 2.570

9.  Daily functioning and symptom factors contributing to attitudes toward antipsychotic treatment and treatment adherence in outpatients with schizophrenia spectrum disorders.

Authors:  J Leijala; O Kampman; J Suvisaari; S Eskelinen
Journal:  BMC Psychiatry       Date:  2021-01-13       Impact factor: 3.630

10.  Beliefs about health, health risks and health expectations from the perspective of people with a psychotic disorder.

Authors:  Sally Hultsjö; Susanne Syren
Journal:  Open Nurs J       Date:  2013-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.